Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ETC-1002 in type 2 diabetes
NCT01607294Phase 2Completed
- Sponsor
- Esperion Therapeutics
- Start
- Apr 2012
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bempedoic acid in hyperlipidemia, sponsored by Esperion Therapeutics. Started Apr 2012; status: completed.
02
Drugs
bempedoic acid
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT01607294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01607294.